Given their antiinflammatory properties, there has been some speculation that GLP-1 medicines could impair host immune defenses, but current clinical evidence does not indicate an increased risk of infections or obesity-related cancer (94)
Another study published in the International Journal of Molecular Sciences found that oxidative stress is often a precursor to stroke, and an ischemic stroke can, in turn, increase oxidative stress
Dose: 12 mg/day SubQ (standard dosing, not scalp-specific injections) Scalp injection variant: Some advanced protocols involve injecting very small amounts (0.10.2 mg per site) directly into the scalp near hair follicle clusters, similar to mesotherapy
Please note that when a status is noted as "available," this reflects the most current information from the manufacturer but is not an FDA determination that the shortage has been resolved
Recent clinical wins include: Taltz + Zepbound combination: Delivered superior efficacy in adults with psoriatic arthritis and obesity Orforglipron: Helped patients maintain weight loss after switching from injectables to oral therapy a potentially massive market expansion Retatrutide: The companys triple agonist delivered average weight loss of 71.2 pounds along with substantial osteoarthritis pain relief The orforglipron data matters particularly for the competitive landscape
K., Srivastava, P
